New and updated preclinical data presented at the American Association for Cancer Research annual meeting in Orlando, Fla., by: Actinium Pharmaceuticals, Ankyra Therapeutics, Bicara Therapeutics, Bridge Biotherapeutics, Cantargia, Celcuity, Evolveimmune Therapeutics, Genprex, Harpoon Therapeutics, Hotspot Therapeutics, Immvira, Imunon, Indaptus Therapeutics, Moleculin Biotech, Nutcracker Therapeutics, Onchilles Pharma, Oncoresponse, Oric Pharmaceuticals, Orum Therapeutics, Panbela Therapeutics, Replicate Bioscience, Sensei Biotherapeutics, Sutro Biopharma, Tango Therapeutics, Tonix Pharmaceuticals, Triumvira Immunologics, Vincera Pharma, Wugen, Zymeworks.